West Pharmaceutical Services is hooking up with Corning. As part of an exclusive long-term deal, West is making a multimillion-dollar capital and R&D investment in its new partner to advance drug ...
—Learn More About Halo Pharma’s New Sterile Manufacturing Capabilities at DCAT Week 2025— The Noramco Group, an integrated North American-based API and drug product supply chain product and services ...
Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Fill-Finish Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by adding sterile injectable manufacturing capabilities.
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the ...
The investment includes the installation of a high-speed, state-of-the-art Groninger UFVN FlexFill syringe, cartridge, and vial filling line and a SKAN isolator to enhance production efficiency and ...
WILMINGTON, Del. & WHIPPANY, N.J.--(BUSINESS WIRE)--The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback